ALT
Altimmune, Inc.
$3.12
+0.01 (+0.32%)
At close · Jul 9
Market Cap
$593.15M
Shares
194,474,154
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$41K
+105%
FY2025
Net Income
-$88.09M
+7.3%
FY2025
Operating Margin
-230460.98%
+285399pp
FY2025
Diluted EPS
-$1.00
+25.4%
FY2025
Operating Cash Flow
-$67.54M
+15.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $41K | $20K | $426K | -$68K | $4.41M | $8.19M | $5.8M | $10.33M | $10.74M | $3.24M | — | — | — | — | $24.27M | $20.99M | |
| $244.18K | — | — | — | — | — | — | — | — | — | $168.15K | -$54.58K | -$210.4K | — | — | — | — | |
| $66.8M | $66.43M | $82.23M | $65.8M | $70.54M | $74.54M | $49.77M | $17.77M | $18.46M | $18.41M | $7.22M | $5.13M | $9.32M | $15.29M | $19.51M | $21.22M | $20.88M | |
| $30.16M | $28.1M | $20.97M | $18.14M | $17.13M | $15.41M | $13.21M | $8.5M | $9.77M | $8.46M | $7.11M | $6.22M | $10.91M | $13.28M | $11.63M | $14.31M | $18.02M | |
| — | — | — | — | -$205K | $551.3K | $428.88K | $387.32K | — | — | — | — | — | — | $303.92K | $461.07K | $1.02M | |
| — | — | — | — | — | — | — | — | — | — | $0 | $2.55M | $0 | $0 | — | — | — | |
| $96.95M | $94.53M | $103.19M | $96.36M | $87.67M | $101.32M | $62.98M | $27.27M | $53.17M | $62.78M | $14.33M | $14.04M | $20.38M | $28.75M | $31.44M | $35.99M | $44.55M | |
| -$96.92M | -$94.49M | -$103.17M | -$95.93M | -$87.74M | -$96.91M | -$54.8M | -$21.46M | -$42.83M | -$52.05M | -$11.09M | -$3.4M | -$10.19M | -$10.84M | -$6.27M | -$11.73M | -$23.55M | |
| — | -230460.98% | -515860% | -22518.54% | — | -2197.6% | -669.5% | -370% | -414.61% | -484.67% | -342.74% | — | — | — | — | -48.32% | -112.19% | |
| — | — | — | — | -$87.95M | -$96.36M | -$54.37M | -$21.08M | — | — | — | — | — | — | -$5.96M | -$11.26M | -$22.53M | |
| $2.7M | $1.64M | $9000 | $35K | $8000 | $5000 | $9421 | $2244 | $297.09K | $162.14K | $38.5K | $54.58K | $210.4K | $366.71K | $324.75K | $54.57K | $5.94M | |
| $8.9M | $7.54M | $8.07M | $7.35M | $2.87M | $203K | $322.51K | $843.41K | $226.6K | $47.58K | $1047 | — | — | $2575 | $17.81K | $16.66K | $6955 | |
| $5.84M | $5.72M | $8.11M | $7.48M | $2.83M | -$176K | $337.24K | $886.3K | -$2.49M | -$18.51K | $4851 | $23.84K | $297.66K | -$817.4K | $1.54M | $7.93M | -$11.3M | |
| -$91.08M | -$88.77M | -$95.06M | -$88.45M | -$84.91M | -$97.09M | -$54.46M | -$20.58M | -$45.32M | -$52.06M | -$11.09M | -$3.38M | -$9.89M | -$11.66M | -$4.72M | -$3.8M | -$34.85M | |
| — | -$681K | — | — | -$197K | — | -$5.42M | -$58.5K | -$6.15M | -$5.64M | $0 | $61.75K | $61.75K | $61.75K | $195.53K | — | — | |
| -$91.08M | -$88.09M | -$95.06M | -$88.45M | -$84.71M | -$97.09M | -$49.04M | -$20.52M | -$39.17M | -$46.43M | -$11.09M | -$3.44M | -$9.96M | -$11.72M | -$4.92M | -$3.8M | -$34.85M | |
| — | -214860.98% | -475295% | -20762.21% | — | -2201.59% | -599.2% | -353.71% | -379.16% | -432.33% | -342.59% | — | — | — | — | -15.65% | -166% | |
| — | — | — | — | — | — | -$49.04M | -$20.97M | -$42.48M | -$51.36M | -$11.46M | — | — | — | — | — | — | |
| -$40.91M | — | — | — | — | — | — | — | -$39.63M | -$43.43M | -$17.89M | -$3.21M | -$9.97M | -$11.72M | — | -$4.04M | -$34.79M | |
| USD/shares | — | -$1.00 | -$1.34 | -$1.66 | -$1.81 | -$2.35 | -$1.91 | — | — | — | $2.97 | -$0.05 | -$0.17 | — | — | — | — |
| USD/shares | — | -$1.00 | -$1.34 | -$1.66 | -$1.81 | -$2.35 | -$1.91 | — | — | — | $2.95 | -$0.05 | -$0.17 | — | — | — | — |
| shares | — | 88.1M | 71M | 53.25M | 46.93M | 41.28M | 25.64M | 13.12M | 2.8M | 431.88K | 65.31M | 63.99M | 57.54M | 50.66M | 48.32M | 47.33M | 32.31M |
| shares | — | 88.1M | 71M | 53.25M | 46.93M | 41.28M | 25.64M | 13.12M | 2.8M | 431.88K | 65.66M | 63.99M | 57.54M | 50.66M | 48.32M | 47.33M | 32.31M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.05×
EV/EBIT
—
Biotechnology median 25.73×
P/E (TTM)
—
Biotechnology median 7.68×